Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications

Autor: Selvakumar, Pkc, Kabbany, Mn, Nobili, V, Alkhouri, N.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3686::7ff7082edefc067a1ac00d6c2ad8c2e7
http://hdl.handle.net/11573/1027676

Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease.

Autor: Castillo-Leon E; Department of Pediatrics, School of Medicine, Emory University, Atlanta, GA 30322, USA.; Department of Pediatrics, Morehouse School of Medicine, Atlanta, GA 30310, USA., Morris HL; Target RWE, Durham, NC 27703, USA., Schoen C; Target RWE, Durham, NC 27703, USA., Bilhartz J; Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109, USA., McKiernan P; Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, USA., Miloh T; Pediatric Gastroenterology, Pediatric Transplant Hepatology, Miami Transplant Institute, Miami, FL 33136, USA., Palle S; Division of Gastroenterology, OU Medicine, Oklahoma City, OK 73104, USA., Kabbany MN; Department of Pediatric Gastroenterology, Hepatology, and Nutrition, Cleveland Clinic, Cleveland, OH 44195, USA., Munoz B; Target RWE, Durham, NC 27703, USA., Mospan AR; Target RWE, Durham, NC 27703, USA., Rudolph B; The Children's Hospital at Montefiore, The Pediatric Hospital for Albert Einstein College of Medicine, Bronx, NY 10467, USA., Xanthakos SA; Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's, Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH 45229, USA., Vos MB; Nutrition and Health Sciences Program, Laney Graduate School, Emory University, Atlanta, GA 30322, USA., Target-Nash Investigators

Publikováno v: Children (Basel, Switzerland) [Children (Basel)] 2022 Mar 08; Vol. 9 (3). Date of Electronic Publication: 2022 Mar 08.

Performance Characteristics, Intra- and Inter-operator Agreement of Transient Elastography in Pediatric Nonalcoholic Fatty Liver Disease.

Autor: Mandelia C; Department of Pediatric Gastroenterology & Hepatology, Cleveland Clinic Children's Hospital.; Division of Pediatric Gastroenterology, East Carolina University Brody School of Medicine, Greenville, NC., Kabbany MN; Department of Pediatric Gastroenterology & Hepatology, Cleveland Clinic Children's Hospital., Worley S; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH., Conjeevaram Selvakumar PK; Department of Pediatric Gastroenterology & Hepatology, Cleveland Clinic Children's Hospital.; Bon Secours Pediatric Gastroenterology Associates, Richmond, VA.

Publikováno v: Journal of pediatric gastroenterology and nutrition [J Pediatr Gastroenterol Nutr] 2021 Mar 01; Vol. 72 (3), pp. 430-435.

Obesity-linked suppression of membrane-bound O -acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease.

Autor: Helsley RN; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States.; Department of Internal Medicine, University of Cincinnati, Cincinnati, United States., Varadharajan V; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States., Brown AL; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States., Gromovsky AD; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States., Schugar RC; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States., Ramachandiran I; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States., Fung K; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States., Kabbany MN; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States., Banerjee R; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States., Neumann CK; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States., Finney C; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States., Pathak P; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States., Orabi D; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States., Osborn LJ; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States., Massey W; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States., Zhang R; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States., Kadam A; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States., Sansbury BE; Center for Experimental Therapeutics & Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, United States., Pan C; Department of Medicine, University of California, Los Angeles, Los Angeles, United States.; Department of Microbiology, University of California, Los Angeles, Los Angeles, United States.; Department of Human Genetics, University of California, Los Angeles, Los Angeles, United States., Sacks J; Department of Pathobiology, Cleveland Clinic, Cleveland, United States., Lee RG; Cardiovascular Group, Antisense Drug Discovery, Ionis Pharmaceuticals, Inc, Carlsbad, United States., Crooke RM; Cardiovascular Group, Antisense Drug Discovery, Ionis Pharmaceuticals, Inc, Carlsbad, United States., Graham MJ; Cardiovascular Group, Antisense Drug Discovery, Ionis Pharmaceuticals, Inc, Carlsbad, United States., Lemieux ME; Bioinfo, Plantagenet, Canada., Gogonea V; Department of Chemistry, Cleveland State University, Cleveland, United States., Kirwan JP; Department of Pathobiology, Cleveland Clinic, Cleveland, United States., Allende DS; Department of Anatomical Pathology, Cleveland Clinic, Cleveland, United States., Civelek M; Department of Biomedical Engineering, University of Virginia, Charlottesville, United States., Fox PL; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States., Rudel LL; Department of Pathology, Section on Lipid Sciences, Wake Forest University School of Medicine, Winston-Salem, United States., Lusis AJ; Department of Medicine, University of California, Los Angeles, Los Angeles, United States.; Department of Microbiology, University of California, Los Angeles, Los Angeles, United States.; Department of Human Genetics, University of California, Los Angeles, Los Angeles, United States., Spite M; Center for Experimental Therapeutics & Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, United States., Brown JM; Department of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States.

Publikováno v: ELife [Elife] 2019 Oct 17; Vol. 8. Date of Electronic Publication: 2019 Oct 17.

Lean Nonalcoholic Fatty Liver Disease: Should It Be Considered in Lean Adolescents With Elevated Liver Enzymes?

Autor: Conjeevaram Selvakumar PK; Department of Pediatric Gastroenterology and Hepatology., Kabbany MN; Department of Pediatric Gastroenterology and Hepatology., Alkhouri N; Department of Pediatric Gastroenterology and Hepatology.; Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH.; Texas Liver Institute.; University of Texas Health San Antonio, San Antonio, TX.

Publikováno v: Journal of pediatric gastroenterology and nutrition [J Pediatr Gastroenterol Nutr] 2019 Feb; Vol. 68 (2), pp. e40-e41.